Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Target gene-independent functions of MYC oncoproteins
Apoorva Baluapuri, Elmar Wolf, Martin Eilers
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 5, pp. 255-267
Open Access | Times Cited: 252

Showing 1-25 of 252 citing articles:

The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
Renumathy Dhanasekaran, Anja Deutzmann, Wadie D. Mahauad‐Fernandez, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 1, pp. 23-36
Open Access | Times Cited: 555
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
Sarah K. Madden, Aline D. de Araujo, Mara Gerhardt, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 308
MYC protein interactors in gene transcription and cancer
Corey Lourenco, Diana Resetca, Cornelia Redel, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 9, pp. 579-591
Closed Access | Times Cited: 246
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 223
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 158
EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis
Jun Wang, Xufen Yu, Weida Gong, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 3, pp. 384-399
Open Access | Times Cited: 140
MYCN Function in Neuroblastoma Development
Jörg Otte, Cecilia Dyberg, Adena Pepich, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 128
Human embryonic genome activation initiates at the one-cell stage
Maki Asami, Brian Lam, Marcella Ma, et al.
Cell stem cell (2021) Vol. 29, Iss. 2, pp. 209-216.e4
Open Access | Times Cited: 104
EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation
Liyuan Wang, Chan Chen, Zemin Song, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 103
MYC: a complex problem
Subhendu Das, Brian A. Lewis, David Levens
Trends in Cell Biology (2022) Vol. 33, Iss. 3, pp. 235-246
Open Access | Times Cited: 77
Interaction modules that impart specificity to disordered protein
Kateřina Čermáková, H. Courtney Hodges
Trends in Biochemical Sciences (2023) Vol. 48, Iss. 5, pp. 477-490
Open Access | Times Cited: 45
Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer
Hui Xu, Haidan Luo, Jiayu Zhang, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 42
A review of healthy role of dietary fiber in modulating chronic diseases
Mengyuan Li, Sen Ma
Food Research International (2024) Vol. 191, pp. 114682-114682
Closed Access | Times Cited: 35
Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
MYC phase separation selectively modulates the transcriptome
Junjiao Yang, Chan-I Chung, Jessica Koach, et al.
Nature Structural & Molecular Biology (2024) Vol. 31, Iss. 10, pp. 1567-1579
Closed Access | Times Cited: 16
Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
Win Topatana, Sarun Juengpanich, Shijie Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 134
Targeting transcription cycles in cancer
Stephin J. Vervoort, Jennifer R. Devlin, Nicholas Kwiatkowski, et al.
Nature reviews. Cancer (2021) Vol. 22, Iss. 1, pp. 5-24
Closed Access | Times Cited: 101
Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein
Marie‐Eve Beaulieu, Francisco Castillo, Laura Soucek
Cells (2020) Vol. 9, Iss. 4, pp. 1038-1038
Open Access | Times Cited: 82
Combined inhibition of Aurora-A and ATR kinases results in regression of MYCN-amplified neuroblastoma
Isabelle Roeschert, Evon Poon, Anton G. Henssen, et al.
Nature Cancer (2021) Vol. 2, Iss. 3, pp. 312-326
Open Access | Times Cited: 76
Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery
Hui Liu, Kangdong Liu, Zigang Dong
Cancer Research (2020) Vol. 81, Iss. 1, pp. 18-26
Open Access | Times Cited: 75
Molecular Crosstalk Between MYC and HIF in Cancer
Yanping Li, Xiao-Xin Sun, David Z. Qian, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 71
MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1
Tessa M. Popay, Jing Wang, Clare M. Adams, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 70
MYC assembles and stimulates topoisomerases 1 and 2 in a “topoisome”
Subhendu Das, Vladislav Kuzin, Donald P. Cameron, et al.
Molecular Cell (2021) Vol. 82, Iss. 1, pp. 140-158.e12
Open Access | Times Cited: 68
Targeting MYCN in Pediatric and Adult Cancers
Zhihui Liu, Samuel S. Chen, Saki Clarke, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 67
Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis
Xue Han, Chune Ren, Chao Lü, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 9, pp. 1864-1873
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top